Diagnostic accuracy
Diagnostic TestThe aim is to obtain a regional measure of brain glucose metabolism in each normal subject because this is a functional measure of brain activity.
NCT Number: NCT06164938
The aim of the study is to obtain information on cerebral glucose metabolism measured with the 18F-FDG PET technique in normal subjects without current or previous neurological or psychiatric pathologies in order to use the data obtained for voxel-based statistical analyzes for comparison with individual subjects ( patients with disease neurological or psychiatric) which will be evaluated with the same method to improve the specificity and diagnostic sensitivity of the FDG PET exam.
The objective is to obtain a functional measure of brain glucose metabolism in every normal subject because this is a functional measure of brain activity. The subjects will represent different decades of age to have a wider range of comparison with patients.
Looking for future studies?
Notify Me40 year–80 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
The aim is to obtain a regional measure of brain glucose metabolism in each normal subject because this is a functional measure of brain activity.
Time frame: 1 year
Study of glucose metabolism with 18 F FDG PET in normal subjects without current or previous neurological or psychiatric pathologies in order to use the data obtained for statistical analyzes for comparison with individual subjects (patients with neurological or psychiatric) which will be evaluated with the same method to improve the diagnostic sensitivity of the FDG PET exam.
IRCCS San Raffaele
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04863859
Alzheimer Disease, Brain Diseases
Blacksburg, Virginia, United States
View Trial DetailsNCT07244900
Basal Ganglia Diseases, Brain Diseases
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05733494
Deglutition Disorders, Digestive System Diseases
Milan, Milano, Italy
View Trial DetailsNCT06625710
Neuro-Degenerative Disease
Seoul, South Korea
View Trial Details